You are viewing: US Diagnostic Contract Manufacturing Market analysis

The US Diagnostic Contract Manufacturing Market was valued at $5032.6 Million in 2023 and projected to reach to $8335.9 Million by 2028, representing a compound annual growth rate of 10.6%. The US diagnostic contract manufacturing market is poised for sustained expansion through 2028, driven by increasing demand for point-of-care testing, molecular diagnostics, and immunoassay platforms.

US Diagnostic Contract Manufacturing Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Diagnostic Contract Manufacturing Market Trends and Insights

  • The US market benefits from advanced healthcare infrastructure, robust regulatory frameworks, and a strong presence of diagnostic device manufacturers seeking specialized outsourcing partners.
  • In 2023, the US accounted for a significant portion of North American diagnostic contract manufacturing activity, driven by increasing demand for point-of-care testing, molecular diagnostics, and immunoassay platforms. Growth in the US market through 2028 is fueled by rising healthcare expenditures, accelerating adoption of personalized medicine, and manufacturers' preference for cost-efficient contract manufacturing solutions.
  • The US diagnostic contract manufacturing sector is characterized by consolidation among service providers and expansion of manufacturing capabilities to meet stringent FDA and quality standards.
  • By 2028, the US market is expected to capture increased outsourcing volumes as domestic and international diagnostic companies leverage specialized contract manufacturers to enhance operational efficiency and reduce capital investment..

Key Market Statistics

  • CAGR (2023-2028) 10.6% CAGR
  • Market Size, 2023 ~USD 5032.6 Million
  • Forecast, 2028 ~USD 8335.9 Million
  • Country US

US Diagnostic Contract Manufacturing Market Overview

Market Valuation & Growth :

The US diagnostic contract manufacturing market reached $5,032.6 million in 2023 and is forecast to grow to $8,335.9 million by 2028, driven by a robust 10.6% CAGR, outpacing many other healthcare segments.

Advanced Healthcare Infrastructure :

The US benefits from world-class healthcare infrastructure, FDA regulatory expertise, and established quality standards that attract diagnostic device manufacturers to leverage specialized contract manufacturing partners for competitive advantage.

Outsourcing Demand Surge :

US diagnostic device manufacturers increasingly outsource production to contract manufacturers to reduce capital expenditure, accelerate time-to-market, and focus on core competencies in product development and commercialization.

Regulatory & Compliance Excellence :

Strong FDA compliance frameworks and ISO certifications in the US create a trusted ecosystem where contract manufacturers deliver validated, quality-assured diagnostic products meeting stringent regulatory requirements.

US Diagnostic Contract Manufacturing Market Dynamics

  • Manufacturers are investing in automation, digital integration, and capacity expansion to meet rising volumes from both established OEMs and emerging diagnostic innovators.
  • The shift toward personalized medicine and home-based testing solutions further accelerates outsourcing adoption.
  • Consolidation among contract manufacturers and strategic partnerships with technology providers will reshape the competitive landscape, enabling faster innovation cycles and improved operational efficiency across the US market..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The US diagnostic contract manufacturing market reached $5,032.6 million in 2023 and will grow to $8,335.9 million by 2028 at a 10.6% CAGR.
    • The US market is driven by demand for outsourced manufacturing of point-of-care, molecular, and immunoassay diagnostic platforms.
    • Regulatory compliance with FDA standards and quality certifications remains a critical competitive advantage for US contract manufacturers.
    • The US market is consolidating, with leading contract manufacturers expanding capacity and capabilities to serve growing diagnostic device portfolios.

    Diagnostic Contract Manufacturing Market Report Scope

    Report Metric Details
    Base Year 2023
    Fastest Growing Segment CARDIOLOGY (Application)
    Forecast Period 2023-2028
    Growth Rate CAGR of 11.5% from 2023 to 2028
    Largest Segment DEVICE DEVELOPMENT AND MANUFACTURING SERVICES (Service)
    Market Size Base Year (Billions) ~USD 26.05 (2023)
    Revenue Forecast (Billions) ~USD 44.9 (2028)
    Segments Covered Device Type, Type, Service, Application

    US Diagnostic Contract Manufacturing Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Device Type

    • Diagnostic Imaging Devices
    • In Vitro Diagnostic Devices
    • Other Devices

    By Type

    • Ct
    • Ivd Consumables
    • Ivd Equipment
    • Mri
    • Other Diagnostic Imaging Devices
    • Ultrasound
    • X-Ray

    By Service

    • Device Development And Manufacturing Services
    • Other Services
    • Packaging And Assembly Services
    • Quality Management Services

    By Application

    • Cardiology
    • Diabetes
    • Gastroenterology
    • Gynecology
    • Infectious Diseases
    • Neurology
    • Oncology
    • Orthopedics
    • Other Applications

    US: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028

    Segment20212022202320242025202620272028CAGR (%)
    CARDIOLOGY235.8260.2292.5328.5368.9414.5464.4519.812.2
    DIABETES375.1401.3437.5476.3518.6565613.86668.8
    INFECTIOUS DISEASES962.91051.71169.91299.61442.81602.31773.41959.810.9
    ONCOLOGY317.9348.7389.8435.2485.8542.6604.4672.411.5
    OTHER APPLICATIONS661.7705.8767832.6903.7981.61063.111508.4
    TOTAL2553.42767.73056.73372.23719.841064519.1496810.2

    US: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028

    Segment20212022202320242025202620272028CAGR (%)
    GASTROENTEROLOGY102.4113.6128.5145.1163.6184.4207.2232.212.6
    GYNECOLOGY91.5101.9115.6130.9148.3168.1190214.513.2
    OTHER APPLICATIONS220.3237.3260.4285.5312.9343.2375.34109.5
    TOTAL414.2452.8504.5561.5624.8695.7772.5856.711.2

    Target Audience

    • Diagnostic Device OEMs : US-based and international diagnostic manufacturers need market intelligence to evaluate contract manufacturing partnerships, assess capacity availability, negotiate pricing, and optimize supply chain strategies in the American market.
    • Contract Manufacturing Companies : Existing and prospective contract manufacturers require detailed US market data to identify growth opportunities, benchmark performance against competitors, plan capacity investments, and develop targeted sales strategies for OEM clients.
    • Private Equity & Investors : Investment firms evaluating acquisition targets, portfolio companies, or new ventures in diagnostic manufacturing need US market sizing, growth forecasts, and competitive dynamics to assess investment returns and strategic fit.
    • Healthcare Consultants & Advisors : Management consultants, healthcare advisors, and business strategists require authoritative US market data to support client recommendations on outsourcing decisions, market entry strategies, and operational optimization initiatives.
    • Regulatory & Quality Professionals : Compliance officers, quality assurance leaders, and regulatory specialists need US-specific insights on manufacturing standards, FDA requirements, and best practices to ensure partner selection and operational excellence in diagnostic production.

    Reasons to Buy this Report

    • Accurate US Market Sizing : Obtain precise valuation data for the US market ($5.0B in 2023) with detailed forecasts through 2028, enabling accurate budgeting, investment planning, and competitive benchmarking specific to the American diagnostic manufacturing landscape.
    • Growth Trajectory & CAGR Insights : Understand the 10.6% CAGR trajectory for the US market, identifying high-growth segments and timing opportunities for capacity expansion, M&A activity, and strategic partnerships within the domestic diagnostic manufacturing ecosystem.
    • Regulatory & Compliance Intelligence : Gain insights into FDA requirements, quality standards, and compliance frameworks driving US contract manufacturer selection, helping OEMs and investors identify partners with proven regulatory expertise and validated manufacturing capabilities.
    • Competitive Positioning Strategy : Leverage US-specific market analysis to benchmark operational performance, identify market gaps, assess competitor strategies, and develop targeted go-to-market approaches for diagnostic contract manufacturing services in America.
    • Investment & Partnership Decisions : Make informed decisions on facility investments, technology acquisitions, and strategic partnerships by understanding US market dynamics, outsourcing trends, and emerging opportunities in diagnostic device manufacturing outsourcing.

    Frequently asked questions

    What is the current size of the US diagnostic contract manufacturing market?

    The US diagnostic contract manufacturing market was valued at $5,032.6 million in 2023 and is expected to reach $8,335.9 million by 2028.

    What is the projected growth rate for the US market?

    The US diagnostic contract manufacturing market is projected to grow at a compound annual growth rate (CAGR) of 10.6% from 2023 to 2028.

    What are the primary drivers of growth in the US market?

    Key growth drivers in the US market include rising healthcare expenditures, adoption of personalized medicine, demand for point-of-care diagnostics, and manufacturers' preference for outsourcing to reduce capital costs.

    What regulatory requirements impact US diagnostic contract manufacturers?

    US contract manufacturers must comply with FDA regulations, quality standards (ISO 13485), and Good Manufacturing Practice (GMP) requirements to serve the diagnostic device market.

    Which diagnostic segments are driving demand in the US?

    Point-of-care testing, molecular diagnostics, immunoassay platforms, and specialty diagnostic devices are the primary segments driving contract manufacturing demand in the US.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product/service launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the diagnostic contract manufacturing market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

    The four steps involved in estimating the market size are

    Collecting Secondary Data

    The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the diagnostic contract manufacturing market. A database of the key industry leaders was also prepared using secondary research.

    Collecting Primary Data

    The primary research data was conducted after acquiring knowledge about the diagnostic contract manufacturing market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as clinical laboratories, hospitals, and academic & research institutes) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, and Rest of the World. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

    A breakdown of the primary respondents is provided below:

    Breakdown of Primary Participants:

    Diagnostic Contract Manufacturing Market Size, and Share

    Note 1: *Others include sales managers, marketing managers, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    All major product manufacturers offering various sleep apnea were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value diagnostic contract manufacturing market was also split into various segments and subsegments at the regional and country level based on the following:

    • Product mapping of various manufacturers for each type of diagnostic contract manufacturing market at the regional and country-level 
    • Relative adoption pattern of each diagnostic contract manufacturing market among key application segments at the regional and/or country-level 
    • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
    • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

    Global Diagnostic contract manufacturing Market Size: Botton Up Approach

    Diagnostic Contract Manufacturing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Global Diagnostic contract manufacturing market Size: Top-Down Approach

    Diagnostic Contract Manufacturing Market Size, and Share

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Diagnostic contract manufacturing industry.

    Market Definition

    Diagnostic contract manufacturing is a process wherein a manufacturing company makes diagnostic devices or the components of devices that can be sold later by other companies. Diagnostic device contract manufacturers specialize in a certain process or task and offer expertise due to their frequent practice of manufacturing.

    Key Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global diagnostic contract manufacturing market by device type, service, application, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, challenges, and trends)
    • To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the overall diagnostic contract manufacturing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to four regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence

    Available Customizations

    MarketsandMarkets offers the following customizations for this market report:

    Additional country-level analysis of the Diagnostic contract manufacturing market

    • Profiling of additional market players (up to 5)

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Diagnostic contract manufacturing Market

    Get the Full Diagnostic Contract Manufacturing Market Report

    Full forecast, segment splits, and company analysis for all Diagnostic Contract Manufacturing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status